Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rexinoid Therapy for Poorly Differentiated Thyroid Cancer: A Pilot Clinical Trial and Correlation to Retinoid and PPARy Receptor Expression

NCT00718770 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT00718770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00718770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rexinoid Therapy for Poorly Differentiated Thyroid Cancer: A Pilot Clinical Trial and Correlation to Retinoid and PPARy Receptor Expression
Lead sponsor
University of Colorado, Denver
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2008
Completion date
February 28, 2013
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thyroid cancer